Recombinant allergen molecules: tools to study effector cell activation
The DOI matches its Crossref record.
Abstract
Summary: The IgE antibody‐mediated activation of allergic effector cells is the key pathomechanism underlying the immediate symptoms of Type I allergy, a genetically determined hypersensitivity disease affecting 25% of the population. In recent years important environmental allergens and their epitopes have become available as structurally defined recombinant molecules. In addition, corresponding human monoclonal IgE and IgG antibodies have been isolated. This review summarizes data obtained regarding the three‐dimensional structure of allergens, their IgE epitopes and the recognition of allergens by IgE and IgG antibodies. In particular, we discuss results of recent in vitro and in vivo studies with defined allergen molecules, their epitopes and the corresponding antibodies which support the hypothesis that the density and geometrical arrangement of IgE epitopes on a particular allergen molecule may profoundly affect effector cell activation. If the structural requirements for effector cell activation can be delineated, it may be envisaged that, based on this knowledge, allergens can be converted into hypoallergenic immunogens by reorientation of IgE epitopes. Such allergen derivatives may be used for allergen‐specific immunotherapy with reduced risk of inducing anaphylactic side effects. The authors would like to thank Dr. Peter Valent, Department of Hematology, Vienna General Hospital, Austria, and Dr. Steven C. Almo, Department of Biochemistry, Albert Einstein College of Medicine, New York, USA, for fruitful collaboration regarding effector cell activation and structural biology, respectively. The skilful editorial assistance of Irmgard Lubelik is acknowledged. This work was supported by grant Y078 GEN of the Austrian Science Fund and by the ICP Program of the Austrian Federal Ministry for Education, Science and Culture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics
Canonica, G. W., Ansotegui, I. J., Pawankar, R., Schmid-Grendelmeier, P., van Hage, M., Baena-Cagnani, C. E., Melioli, G., Nunes, C., Passalacqua, G., Rosenwasser, L., et al. (2013) · World Allergy Organization Journal · doi:10.1186/1939-4551-6-17 · Cited by 432
The future of antigen-specific immunotherapy of allergy
Valenta, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri824 · Cited by 314
Self-citationA Protease-Activated Pathway Underlying Th Cell Type 2 Activation and Allergic Lung Disease
Kheradmand, F., Kiss, A., Xu, J., Lee, S.-H., Kolattukudy, P. E., & Corry, D. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5904 · Cited by 305
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals
Hauswirth, A. W., Natter, S., Ghannadan, M., Majlesi, Y., Schernthaner, G.-H., Sperr, W. R., Bühring, H.-J., Valenta, R., & Valent, P. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.125257 · Cited by 169
Self-citationThe crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family
Kaiser, L., Grönlund, H., Sandalova, T., Ljunggren, H.-G., van Hage-Hamsten, M., Achour, A., & Schneider, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304740200 · Cited by 122
Metadata
- Authors
- Valenta, R., & Kraft, D.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2001-02
- Volume
- 179
- Issue
- 1
- Pages
- 119-127
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2103224010
- Cited by
- 87
- References
- 0
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recombinant allergen molecules: tools to study effector cell activation. https://app.cochat.ai/papers/10.1034/j.1600-065x.2001.790112.x
- The paper
- Valenta, R., & Kraft, D. (2001). Recombinant allergen molecules: tools to study effector cell activation. Immunological Reviews. https://doi.org/10.1034/j.1600-065x.2001.790112.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.